» Articles » PMID: 19734090

The Role of Chemokines in Intestinal Inflammation and Cancer

Overview
Specialty Pharmacology
Date 2009 Sep 8
PMID 19734090
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic inflammation is a risk factor for several gastrointestinal malignancies, including colorectal cancer. Recent epidemiological studies and clinical trials demonstrate that long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) markedly reduced the relative risk of colorectal cancer. Chronic inflammation associated with development of cancer is partly driven by the chemokine system. Chemokines are chemoattractant cytokines that recruit leukocytes from the circulatory system to local inflammatory sites. In this review, we highlight recent breakthroughs in our understanding of the role of chemokines in inflammatory bowel disease and colorectal cancer from animal models and human studies. These findings provide a rationale for the development of new anti-inflammatory therapeutic approaches for prevention and/or treatment of inflammatory bowel disease and colorectal cancer.

Citing Articles

Myeloid-Derived Suppressor Cell Accumulation Drives Intestinal Fibrosis through mCCL6/hCCL15 Chemokine-Mediated Fibroblast Activation.

Cheng X, Shao P, Wang X, Jiang J, Chen J, Zhu J Adv Sci (Weinh). 2024; 12(8):e2411711.

PMID: 39739231 PMC: 11848553. DOI: 10.1002/advs.202411711.


Neutrophil prime unique transcriptional responses in intestinal organoids during infection with nontyphoidal serovars.

Lawrence A, Berger R, Hill D, Huang S, Yadagiri V, Bons B mSphere. 2024; 9(12):e0069324.

PMID: 39565098 PMC: 11656734. DOI: 10.1128/msphere.00693-24.


eQTL in diseased colon tissue identifies novel target genes associated with IBD.

Nishiyama N, Silverstein S, Darlington K, Kennedy Ng M, Clough K, Bauer M bioRxiv. 2024; .

PMID: 39464142 PMC: 11507739. DOI: 10.1101/2024.10.14.618229.


A probiotic Limosilactobacillus fermentum GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiome.

Zhou T, Wu J, Khan A, Hu T, Wang Y, Salama E NPJ Sci Food. 2024; 8(1):61.

PMID: 39242568 PMC: 11379937. DOI: 10.1038/s41538-024-00307-5.


Revealing the role of SPP1 macrophages in glioma prognosis and therapeutic targeting by investigating tumor-associated macrophage landscape in grade 2 and 3 gliomas.

Tang W, Lo C, Ma W, Chu A, Tong A, Chung B Cell Biosci. 2024; 14(1):37.

PMID: 38515213 PMC: 10956315. DOI: 10.1186/s13578-024-01218-4.


References
1.
Neuman M . Immune dysfunction in inflammatory bowel disease. Transl Res. 2007; 149(4):173-86. DOI: 10.1016/j.trsl.2006.11.009. View

2.
Sands B . Inflammatory bowel disease: past, present, and future. J Gastroenterol. 2007; 42(1):16-25. PMC: 2780674. DOI: 10.1007/s00535-006-1995-7. View

3.
Dimberg J, Dienus O, Lofgren S, Hugander A, Wagsater D . Expression and gene polymorphisms of the chemokine CXCL5 in colorectal cancer patients. Int J Oncol. 2007; 31(1):97-102. View

4.
Schneider M, Meingassner J, Lipp M, Moore H, Rot A . CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med. 2007; 204(4):735-45. PMC: 2118557. DOI: 10.1084/jem.20061405. View

5.
Kanagawa N, Niwa M, Hatanaka Y, Tani Y, Nakagawa S, Fujita T . CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma. Int J Cancer. 2007; 121(9):2013-2022. DOI: 10.1002/ijc.22908. View